CompaniesByCap
BLCO
Bausch + Lomb Corporation (BLCO)
NYSE · Healthcare

Bausch + Lomb Corporation Revenue 2020–2025

Bausch + Lomb Corporation annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Bausch + Lomb Corporation revenue for the quarter ending March 31, 2026 was 1.2 B, a 9.41% increase year-over-year.
  • Bausch + Lomb Corporation revenue for the twelve months ending March 31, 2026 was 4.9 B, a 9.34% increase year-over-year.
  • Bausch + Lomb Corporation annual revenue for 2025 was 5.1 B, a 6.47% increase from 2024.
  • Bausch + Lomb Corporation annual revenue for 2024 was 4.8 B, a 15.56% increase from 2023.
  • Bausch + Lomb Corporation annual revenue for 2023 was 4.1 B, a 10.03% increase from 2022.
  • Bausch + Lomb Corporation annual revenue for 2022 was 3.8 B.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Bausch + Lomb Corporation (BLCO) — Frequently Asked Questions

Bausch + Lomb Corporation (BLCO) is a publicly traded US company. It has a market capitalization of $5.41B. In fiscal 2025 it reported revenue of $5.10B and net income of -$360M. Explore BLCO's stock price, financial statements, earnings history, margins and key ratios below.

What is Bausch + Lomb Corporation's market cap?

Bausch + Lomb Corporation (BLCO) has a market capitalization of $5.41B.

What is the BLCO stock price?

BLCO trades at $15.29 (+0.20% on the day).

How much revenue does Bausch + Lomb Corporation make?

Bausch + Lomb Corporation reported revenue of $5.10B in fiscal 2025.

Is BLCO profitable?

In fiscal 2025, Bausch + Lomb Corporation reported net income of -$360M.